SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001746473-24-000101
Filing Date
2024-06-17
Accepted
2024-06-17 20:15:21
Documents
1
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1718669714.html 4  
1 FORM 4 wk-form4_1718669714.xml 4 4249
  Complete submission text file 0001746473-24-000101.txt   5730
Mailing Address C/O AEGLEA BIOTHERAPEUTICS, INC. 901 S. MOPAC EXPRESSWAY, SUITE 250 AUSTIN TX 78746
Business Address
Bruhn Suzanne Louise (Reporting) CIK: 0001517790 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39303 | Film No.: 241049887

Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Issuer) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)